Leukemia Research

Tyrosine kinases in AML: where do they fit in?
pp. 217-218(2)
Author: Ilaria R.L.

Comparative gene expression profile of p185^Bcr-Abl versus p210^Bcr-Abl expressing cells
pp. 219-220(2)
Authors: Tipping A.J.; Melo J.V.

The angiogenic status of B-CLL B cells: role of the VEGF receptors
pp. 221-222(2)
Author: Kay N.E.

Treatment of systemic mast cell disease: beyond interferon
pp. 223-224(2)
Author: Tefferi A.

A novel EBV-negative natural killer cell line
pp. 225-227(3)
Author: Wong K.F.

T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma
pp. 229-236(8)
Authors: Aki H.; Tuzuner N.; Ongoren S.; Baslar Z.; Soysal T.; Ferhanoglu B.; Sahinler I.; Aydin Y.; Ulku B.; Aktuglu G.

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies
pp. 237-241(5)
Authors: Hock B.D.; Haring L.F.; Steinkasserer A.; Taylor K.G.; Patton W.N.; McKenzie J.L.

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
pp. 243-248(6)
Authors: Bairey O.; Boycov O.; Kaganovsky E.; Zimra Y.; Shaklai M.; Rabizadeh E.

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature
pp. 249-257(9)
Authors: Hauswirth A.W.; Simonitsch-Klupp I.; Uffmann M.; Koller E.; Sperr W.R.; Lechner K.; Valent P.

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival
pp. 259-266(8)
Authors: Alexandrakis M.G.; Passam F.H.; Sfiridaki K.; Moschandrea J.; Pappa C.; Liapi D.; Petreli E.; Roussou P.; Kyriakou D.S.

T cell receptor gamma (TCRG) gene rearrangements in Brazilian children with acute lymphoblastic leukemia: analysis and implications for the study of minimal residual disease
pp. 267-273(7)
Authors: Scrideli C.A.; Queiroz R.G.P.; Kashima S.; Sankarankutty B.O.M.; Tone L.G.

A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization
pp. 275-284(10)
Authors: Chen I.-M.; Whalen M.; Bankhurst A.; Sever C.E.; Doshi R.; Hardekopf D.; Montgomery K.; Willman C.L.

Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis
pp. 285-294(10)
Authors: Advani A.S.; Dressman H.K.; Quiroz M.; Taylor G.A.; Pendergast A.M.

An in vivo propagated human acute myeloid leukemia expressing ABCA3
pp. 295-299(5)
Authors: Norwood K.; Wang R.-Y.; Hirschmann-Jax C.; Andreeff M.; Brenner M.K.; Goodell M.A.; Wulf G.G.

Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F
pp. 301-306(6)
Authors: Bachmann A.S.; Xu R.; Ratnapala L.; Patil S.S.

Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells
pp. 307-313(7)
Authors: Genty V.; Dine G.; Dufer J.

Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy
pp. 315-319(5)
Authors: Nagasawa M.; Tomizawa D.; Tsuji Y.; Kajiwara M.; Morio T.; Nonoyama S.; Asada M.; Mizutani S.